P. Powell

Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy

A. Heppeler, Sylvie Froidevaux, Helmut R. Mäcke et al. · Chemistry - A European Journal · 1999 · 332 citations

Peptide Engineering, Peptide Science, Peptide Therapeutics +18

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

Marion de Jong, Willem H. Bakker, Eric P. Krenning et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1997 · 212 citations

Promising Somatostatin Analogue, Engineering, Indium-111 Labelling +10

A convenient synthesis of novel bifunctional prochelators for coupling to bioactive peptides for radiometal labelling

Klaus‐Peter Eisenwiener, P. Powell, Helmut R. Mäcke · Bioorganic & Medicinal Chemistry Letters · 2000 · 121 citations

Biochemistry, Natural Sciences, Peptide Engineering +8

Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?

Daniel D. Storch, Martin Béhé, Martin A. Walter et al. · PubMed · 2005 · 92 citations

Preclinical Comparison in AR4–2J Tumor-Bearing Mice of Four Radiolabeled 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Somatostatin Analogs for Tumor Diagnosis and Internal Radiotherapy*

Sylvie Froidevaux, A. Heppeler, Alex N. Eberlé et al. · Endocrinology · 2000 · 60 citations · Full text